Leigh Anne Tang, Michelle Gomez, Uday Suresh, Kristopher A Kast, Robert A Becker, Thomas J Reese, Colin G Walsh, Jessica S Ancker
{"title":"推荐阿片类药物使用障碍治疗的预测模型的临床医生观点。","authors":"Leigh Anne Tang, Michelle Gomez, Uday Suresh, Kristopher A Kast, Robert A Becker, Thomas J Reese, Colin G Walsh, Jessica S Ancker","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Predictive models that have been made available as clinical decision support systems have not always been used. <b>Objectives:</b> This qualitative study aimed to identify factors that might impact the uptake of a predictive model recommending either methadone or buprenorphine as medication for opioid use disorder (MOUD) in the inpatient setting. <b>Methods:</b> We conducted semi-structured interviews with clinicians who prescribe MOUD and performed a combined deductive and inductive content analysis using a socio-technical model. <b>Results:</b> Thirteen clinicians were interviewed. Non-specialists trusted their specialist peers to lead MOUD decisions and claimed they would trust a tool endorsed by experts and the institution. Clinicians expected the model to follow clinical reasoning, which involves considering factors that are not well-captured by the electronic health record (e.g., housing status, access to care, facility preferences). <b>Conclusion:</b> Predictive models for MOUD should be designed to foster appropriate trust given the tool's purpose, process, limitation, and performance.</p>","PeriodicalId":72180,"journal":{"name":"AMIA ... Annual Symposium proceedings. AMIA Symposium","volume":"2024 ","pages":"1109-1118"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099360/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinician Perspectives on a Predictive Model for Recommending Opioid Use Disorder Treatment.\",\"authors\":\"Leigh Anne Tang, Michelle Gomez, Uday Suresh, Kristopher A Kast, Robert A Becker, Thomas J Reese, Colin G Walsh, Jessica S Ancker\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Predictive models that have been made available as clinical decision support systems have not always been used. <b>Objectives:</b> This qualitative study aimed to identify factors that might impact the uptake of a predictive model recommending either methadone or buprenorphine as medication for opioid use disorder (MOUD) in the inpatient setting. <b>Methods:</b> We conducted semi-structured interviews with clinicians who prescribe MOUD and performed a combined deductive and inductive content analysis using a socio-technical model. <b>Results:</b> Thirteen clinicians were interviewed. Non-specialists trusted their specialist peers to lead MOUD decisions and claimed they would trust a tool endorsed by experts and the institution. Clinicians expected the model to follow clinical reasoning, which involves considering factors that are not well-captured by the electronic health record (e.g., housing status, access to care, facility preferences). <b>Conclusion:</b> Predictive models for MOUD should be designed to foster appropriate trust given the tool's purpose, process, limitation, and performance.</p>\",\"PeriodicalId\":72180,\"journal\":{\"name\":\"AMIA ... Annual Symposium proceedings. AMIA Symposium\",\"volume\":\"2024 \",\"pages\":\"1109-1118\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099360/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AMIA ... Annual Symposium proceedings. AMIA Symposium\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMIA ... Annual Symposium proceedings. AMIA Symposium","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Clinician Perspectives on a Predictive Model for Recommending Opioid Use Disorder Treatment.
Background: Predictive models that have been made available as clinical decision support systems have not always been used. Objectives: This qualitative study aimed to identify factors that might impact the uptake of a predictive model recommending either methadone or buprenorphine as medication for opioid use disorder (MOUD) in the inpatient setting. Methods: We conducted semi-structured interviews with clinicians who prescribe MOUD and performed a combined deductive and inductive content analysis using a socio-technical model. Results: Thirteen clinicians were interviewed. Non-specialists trusted their specialist peers to lead MOUD decisions and claimed they would trust a tool endorsed by experts and the institution. Clinicians expected the model to follow clinical reasoning, which involves considering factors that are not well-captured by the electronic health record (e.g., housing status, access to care, facility preferences). Conclusion: Predictive models for MOUD should be designed to foster appropriate trust given the tool's purpose, process, limitation, and performance.